Baxter to pay $10 million for dialysis solution plant
This article was originally published in Clinica
Executive Summary
Baxter Healthcare has agreed to pay ML Laboratories $10m for a manufacturing plant in Liverpool, UK. The facility is used to make icodextrin, the glucose polymer that forms the basis of the peritoneal dialysis solution Baxter markets as Extraneal.